Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-07-10
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Shimoda Kazuya
九州大学 第1内科
-
三木 義男
東京医歯大 難治疾患研 疾患医科学研究系分子遺伝分野
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Ohtake Shigeki
琉球大学 医学部血液免疫検査学分野
-
Ohtake S
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Ohtake Shigeki
Department Of Laboratory Science Kanazawa University Graduate School Of Medical Science
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
DOBASHI Nobuaki
Jikei University Hospital
-
NAKASEKO Chiaki
Chiba University Hospital
-
KIYOI Hitoshi
Nagoya University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kiyoi Hitoshi
豊橋市民病院 血液･腫瘍内科
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Dobashi Nobuaki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shinagawa Katsuji
岡山大学 第2内科
-
Nakaseko Chiaki
Department Of Clinical Cell Biology And Medicine Chiba University Graduate School Of Medicine
-
Sakura Tohru
群馬大学 医学系研究科生体統御内科学
-
Sakura T
Department Of Medicine Saiseikai Maebashi Hospital
-
Ohtake Shigeki
Department Of Clinical Laboratory Sciences Graduate School Of Medical Sciences Kanazawa University
-
Usui N
Jikei University Hospital
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Kamiya Yoshikazu
愛知がんセンター 血液･細胞療法部
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Okayama Kenichi
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Shinjo Kaori
浜松医科大学 内科学第3
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
SHIGENO Kazuyuki
Department of Internal Medicine, Hamamatsu University School of Medicine
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
SAKURA Toru
Department of Internal Medicine, Saiseikai Maebashi Hospital
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Yahagi Yuichi
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Minami S
Nagasaki Cml Study Group
-
Minami S
(tottori University) United Graduate School Yamaguchi University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University School Of Medicine
-
Shimoda Kazuya
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
MITSUI Yoko
Department of Surgery
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Yamao Kenji
Department Of Gastroenterology Aichi Cancer Center Central Hospital
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
Katayama Yoshio
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Masaki Y
Department Of Hematology And Immunology Kanazawa Medical University
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Morita Yasuyoshi
Kinki Univ. School Of Medicine Osaka Jpn
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Takahara Shinobu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Morishita Yasuyuki
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Ohnishi Kazunori
Department Of Dermatology Gunma University Graduate School Of Medicine
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Miki Yoshio
Department Of Human Genome Analysis Cancer Chemotherapy Center Japanese Foundation For Cancer Resear
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Usui Noriko
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Kimura Yukihiko
First Department Of Internal Medicine Tokyo Medical College
-
Fujita Hiroyuki
Department Of Environmental Immuno-dermatology Yokohama City University Graduate School Of Medicine
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Sakura Tohru
Division Of Hematology Saiseikai Maebashi Hospital
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
KOBAYASHI Yukio
Division of Hematology, National Cancer Center Hospital
-
OHWADA Chikako
Department of Hematology, Chiba University Hospital
-
MIYAZAKI Yasushi
Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences
-
MIYAWAKI Shuichi
Hematology Division, Tokyo Metropolitan Ohtsuka Hospital
-
Ohwada Chikako
Department Of Hematology Chiba University Hospital
-
Fujita Hiroyuki
Department Of Hematology Yokohama City University Medical Center
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Of Medical Science
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Kanazawa University
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Sakura Toru
Department Of Hematology Saiseikai Maebashi Hospital
-
Miyazaki Yasushi
Atomic Bomb Disease And Hibakusha Medicine Unit Department Of Hematology Atomic Bomb Disease Institute Nagasaki University Graduate School Of Biomedical Sciences
-
Mikami Yuzuru
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Ohnishi Kazunori
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Mori Sayaka
Department Of Clinical Laboratory Nagasaki University Hospital
-
SHIGENO Kazuyuki
Department of Internal Medicine III, Hamamatsu University School of Medicine
-
DOBASHI Nobuaki
Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- PS-095-1 n0乳癌における再発予後予測システムの検討
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue